[EN] MRGPRX2 ANTAGONISTS AND USES THEREOF<br/>[FR] ANTAGONISTES DE MRGPRX2 ET LEURS UTILISATIONS
申请人:DERMIRA INC
公开号:WO2021092262A1
公开(公告)日:2021-05-14
The present disclosure is directed to use of MrgprX2 antagonists in the treatment of inflammatory disorders, e.g., inflammatory disorders of the skin. This invention is also directed to pharmaceutical compositions comprising a MrgprX2 antagonist and a pharmaceutically or orally acceptable carrier for administration.